Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
Jeffrey Graham(University of Calgary), Daniel Yick Chin Heng(University of Calgary), Aaron R. Hansen(Princess Margaret Cancer Centre), Sun Young Rha(Yonsei University), Benoit Beuselinck(Universitair Ziekenhuis Leuven), Connor Wells(Queen Mary University of London), Felice Pasini(Ospedale Civile Di Ivrea), Sumanta K. Pal(City of Hope), Toni K. Choueiri(Harvard University), Frede Donskov(Aarhus University Hospital), Georg A. Bjarnason(Sunnybrook Health Science Centre), Scott North, I. Alex Bowman(The University of Texas Southwestern Medical Center), Jae‐Lyun Lee(Ulsan College), Anna Paola Fraccon, Ulka N. Vaishampayan(University of Michigan), D. Scott Ernst, Lori Wood(Dalhousie University), Christian Kollmannsberger(BC Cancer Agency), Camillo Porta(University of Pavia)
Cited by 8
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|2.2k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k